Skip to main content
Log in

Substance P modulates properties of normal and diabetic dermal fibroblasts

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

Dermal fibroblasts play essential roles in wound healing. However, they lose their normal regenerative functions under certain pathologic conditions such as in chronic diabetic wounds. Here, we show that substance P (SP) rescues the malfunctions of dermal fibroblasts in diabetes. SP increased the proliferation of diabetic dermal fibroblasts dose-dependently, although the effect was lower compared to the SP-stimulated proliferation of normal dermal fibroblasts. In contrast to normal dermal fibroblasts, SP increased the expression level of vascular endothelial growth factor (VEGF) and stromal cell-derived factor-1 (SDF-1) in diabetic dermal fibroblast hence, rescuing their angiogenic potential. The cellular characteristics of diabetic dermal fibroblasts modulated by SP would be able to accelerate the wound healing process through faster wound contraction and improved angiogenesis in diabetic chronic wounds. Moreover, SP pretreatment into dermal fibroblasts isolated from diabetic patients would be a promising strategy to develop autologous cell therapy for treating diabetic chronic wounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 2014;6:265sr6.

  2. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007;127:998–1008.

    Article  CAS  PubMed  Google Scholar 

  3. Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care 2013;22:407–408, 410-412.

    Article  CAS  PubMed  Google Scholar 

  4. Epstein EH Jr, Munderloh NH. Human skin collagen. Presence of type I and type III at all levels of the dermis. J Biol Chem 1978;253:1336–1337.

    CAS  PubMed  Google Scholar 

  5. Roh SS, Lee MH, Hwang YL, Song HH, Jin MH, Park SG, et al. Stimulation of the extracellular matrix production in dermal fibroblasts by velvet antler extract. Ann Dermatol 2010;22:173–179.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835–870.

    CAS  PubMed  Google Scholar 

  7. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453:314–321.

    Article  CAS  PubMed  Google Scholar 

  8. Dubon MJ, Park KS. Substance P enhances the proliferation and migration potential of murine bone marrow-derived mesenchymal stem celllike cell lines. Exp Ther Med 2015;9:1185–1191.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Hong HS, Lee J, Lee E, Kwon YS, Lee E, Ahn W, et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med 2009;15:425–435.

    Article  CAS  PubMed  Google Scholar 

  10. Kant V, Gopal A, Kumar D, Bag S, Kurade NP, Kumar A, et al. Topically applied substance P enhanced healing of open excision wound in rats. Eur J Pharmacol 2013;715:345–353.

    Article  CAS  PubMed  Google Scholar 

  11. Leal EC, Carvalho E, Tellechea A, Kafanas A, Tecilazich F, Kearney C, et al. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype. Am J Pathol 2015;185:1638–1648.

    Article  CAS  PubMed  Google Scholar 

  12. Yang L, Di G, Qi X, Qu M, Wang Y, Duan H, et al. Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor. Diabetes 2014;63:4262–4274.

    Article  CAS  PubMed  Google Scholar 

  13. Kim HJ, Song SB, Choi JM, Kim KM, Cho BK, Cho DH, et al. IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. J Invest Dermatol 2010;130:706–715.

    Article  CAS  PubMed  Google Scholar 

  14. Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep. J Cell Sci 2004;117(Pt 5):667–675.

    Article  CAS  PubMed  Google Scholar 

  15. Robins SP, Milne G, Duncan A, Davies C, Butt R, Greiling D, et al. Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds. J Invest Dermatol 2003;121:267–272.

    Article  CAS  PubMed  Google Scholar 

  16. Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 2006;126:468–476.

    Article  CAS  PubMed  Google Scholar 

  17. Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R, et al. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Transplant 2010;19:399–408.

    Google Scholar 

  18. Johnson KE, Wilgus TA. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Wound Care (New Rochelle) 2014;3:647–661.

    Article  PubMed Central  Google Scholar 

  19. Kishimoto J, Ehama R, Ge Y, Kobayashi T, Nishiyama T, Detmar M, et al. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol 2000;157:103–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden TM, Springer TA. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 2001;166:5749–5754.

    Article  CAS  PubMed  Google Scholar 

  21. Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen 1998;6:135–141.

    Article  CAS  PubMed  Google Scholar 

  22. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93–99.

    Article  CAS  PubMed  Google Scholar 

  23. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cellspecific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999;13:1055–1066.

    Article  CAS  PubMed  Google Scholar 

  24. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176:1375–1379.

    Article  CAS  PubMed  Google Scholar 

  25. Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 1999;79:1479–1487.

    CAS  PubMed  Google Scholar 

  26. Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 1999;134:200–205.

    Article  CAS  PubMed  Google Scholar 

  27. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 2007;204:605–618.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007;117:1249–1259.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Xu X, Zhu F, Zhang M, Zeng D, Luo D, Liu G, et al. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs 2013;197:103–113.

    Article  CAS  PubMed  Google Scholar 

  30. Han SK, Choi KJ, Kim WK. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study. Plast Reconstr Surg 2004;114:1783–1789.

    Article  PubMed  Google Scholar 

  31. Monami M, Vivarelli M, Desideri CM, Ippolito G, Marchionni N, Mannucci E. Autologous skin fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic patients. J Am Podiatr Med Assoc 2011;101:55–58.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ki-Sook Park.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jung, N., Yu, J., Um, J. et al. Substance P modulates properties of normal and diabetic dermal fibroblasts. Tissue Eng Regen Med 13, 155–161 (2016). https://doi.org/10.1007/s13770-016-9085-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-016-9085-2

Key Words

Navigation